135 related articles for article (PubMed ID: 18460647)
1. Elevated levels of circulating procoagulant microparticles in patients with beta-thalassemia intermedia.
Habib A; Kunzelmann C; Shamseddeen W; Zobairi F; Freyssinet JM; Taher A
Haematologica; 2008 Jun; 93(6):941-2. PubMed ID: 18460647
[No Abstract] [Full Text] [Related]
2. Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia.
Kanavaki I; Makrythanasis P; Lazaropoulou C; Tsironi M; Kattamis A; Rombos I; Papassotiriou I
Blood Cells Mol Dis; 2009; 43(3):230-4. PubMed ID: 19654073
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolic complications in beta-thalassemia: Beyond the horizon.
Panigrahi I; Agarwal S
Thromb Res; 2007; 120(6):783-9. PubMed ID: 17346783
[TBL] [Abstract][Full Text] [Related]
4. Generation of procoagulant microparticles in cerebrospinal fluid and peripheral blood after traumatic brain injury.
Morel N; Morel O; Petit L; Hugel B; Cochard JF; Freyssinet JM; Sztark F; Dabadie P
J Trauma; 2008 Mar; 64(3):698-704. PubMed ID: 18332810
[TBL] [Abstract][Full Text] [Related]
5. Hypercoagulable state in five thalassemia intermedia patients.
Bhattacharyya M; Kannan M; Chaudhry VP; Mahapatra M; Pati H; Saxena R
Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195
[TBL] [Abstract][Full Text] [Related]
6. Circulating procoagulant microparticles in patients with venous thromboembolism.
Ay C; Freyssinet JM; Sailer T; Vormittag R; Pabinger I
Thromb Res; 2009 Mar; 123(5):724-6. PubMed ID: 18995886
[No Abstract] [Full Text] [Related]
7. Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells.
Goldschmidt N; Spectre G; Brill A; Zelig O; Goldfarb A; Rachmilewitz E; Varon D
Thromb Haemost; 2008 Nov; 100(5):864-70. PubMed ID: 18989531
[TBL] [Abstract][Full Text] [Related]
8. Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction.
Del Turco S; Basta G; Lazzerini G; Evangelista M; Rainaldi G; Tanganelli P; Christensen JH; Schmidt EB; De Caterina R
Haematologica; 2008 Jun; 93(6):892-9. PubMed ID: 18469350
[TBL] [Abstract][Full Text] [Related]
9. Dying for attention: microparticles and angiogenesis.
Boulanger CM; Tedgui A
Cardiovasc Res; 2005 Jul; 67(1):1-3. PubMed ID: 15904903
[No Abstract] [Full Text] [Related]
10. Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.
Gharagozloo M; Karimi M; Amirghofran Z
Ann Hematol; 2009 Jan; 88(1):21-7. PubMed ID: 18690440
[TBL] [Abstract][Full Text] [Related]
11. Cell-derived microparticles: a new challenge in neuroscience.
Doeuvre L; Plawinski L; Toti F; Anglés-Cano E
J Neurochem; 2009 Jul; 110(2):457-68. PubMed ID: 19457085
[TBL] [Abstract][Full Text] [Related]
12. Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia?
Rousseau A; Favier R; Van Dreden P
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):46-9. PubMed ID: 19564071
[TBL] [Abstract][Full Text] [Related]
13. Impaired interaction of platelets with endothelial progenitor cells in patients with cardiovascular risk factors.
Dernbach E; Randriamboavonjy V; Fleming I; Zeiher AM; Dimmeler S; Urbich C
Basic Res Cardiol; 2008 Nov; 103(6):572-81. PubMed ID: 18604625
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic complications in thalassemic patients: contribution of red blood cells and platelets.
Shenkman B
Thromb Haemost; 2008 Nov; 100(5):735. PubMed ID: 18989511
[No Abstract] [Full Text] [Related]
15. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India.
Italia KY; Jijina FJ; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
Clin Chim Acta; 2009 Sep; 407(1-2):10-5. PubMed ID: 19545554
[TBL] [Abstract][Full Text] [Related]
16. Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand.
Nuntakarn L; Fucharoen S; Fucharoen G; Sanchaisuriya K; Jetsrisuparb A; Wiangnon S
Blood Cells Mol Dis; 2009; 42(1):32-5. PubMed ID: 18951049
[TBL] [Abstract][Full Text] [Related]
17. Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients.
Wang JM; Su C; Wang Y; Huang YJ; Yang Z; Chen L; Wu F; Xu SY; Tao J
J Hum Hypertens; 2009 May; 23(5):307-15. PubMed ID: 19037229
[TBL] [Abstract][Full Text] [Related]
18. Causes and clinical significance of prolonged activated partial thromboplastin times in thalassaemia major.
McFadyen J; Butler J; Malan E; Tran H
Ann Hematol; 2014 May; 93(5):867-8. PubMed ID: 23982928
[No Abstract] [Full Text] [Related]
19. The influence of thermal trauma on pro- and anticoagulant activity of erythrocyte-derived microvesicles.
Levin G; Sukhareva E
Burns; 2016 Nov; 42(7):1528-1533. PubMed ID: 27268106
[TBL] [Abstract][Full Text] [Related]
20. Circulating platelet-derived microparticles and endothelium-derived microparticles may be a potential cause of microthrombosis in patients with osteonecrosis of the femoral head.
Kang P; Shen B; Yang J; Pei F
Thromb Res; 2008; 123(2):367-73. PubMed ID: 18495220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
